Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.

Akimova T, Wang L, Bartosh Z, Christensen LM, Eruslanov E, Singhal S, Aishwarya V, Hancock WW

Open source

DOI
10.3389/fimmu.2024.1426657
Published
2024
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2024.1426657,
  title = {Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.},
  author = {Akimova T and Wang L and Bartosh Z and Christensen LM and Eruslanov E and Singhal S and Aishwarya V and Hancock WW},
  year = {2024},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2024.1426657},
  url = {https://doi.org/10.3389/fimmu.2024.1426657}
}

RIS

TY  - JOUR
TI  - Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.
AU  - Akimova T
AU  - Wang L
AU  - Bartosh Z
AU  - Christensen LM
AU  - Eruslanov E
AU  - Singhal S
AU  - Aishwarya V
AU  - Hancock WW
PY  - 2024
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2024.1426657
UR  - https://doi.org/10.3389/fimmu.2024.1426657
ER  - 

APA

T, A., L, W., Z, B., LM, C., E, E., S, S., V, A., & WW, H. (2024). Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2024.1426657

Source records